Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.4%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a study on oteseconazole (VT-1161) for treating recurrent vulvovaginal candidiasis, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference18%
Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.